This adoptive transfer of myeloid cells models further verified that GPR84 deficiency dominantly inhibited MDSCs accumulation and function to reverse the immunosuppressive tumor microenvironment and enhance the prognosis of malignant tumors. Here, GPR84 is linked to cancer.